Cui Bei-Bei, Wu Yang, Liu Huan, Chen Yi-Dan, Xie Qi-Bing, Yin Geng
Department of Rheumatology and Immunology,West China Hospital,Sichuan University,Chengdu 610041,China.
Department of International Medical Center/Greneral Practice,West China Hospital,Sichuan University,Chengdu 610041,China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Mar;49(2):174-178.
To analyze the clinical features of interstitial pneumonia with autoimmune features (IPAF) and the correlation between them.
We respectively analyzed the patients with interstitial lung disease (ILD) admitted in our hospital from January 2014 to January 2017. The patients who met all priori requirements and at least one feature of one domain were recuited, and the clinical features and autoimmune diseases related prognosis were analyzed.
There were 90 patients recruited,including 38 patients completely met IPAF classification criteria and 52 patients who incompletely met. The average age was (62.34±14.98) yr.. The pneumonia pattern of complete IPAF patients was non-specific interstitial pneumonia (NSIP), while it was usually interstitial pneumonia (UIP) in the incomplete IPAF patients. During follow-up,11 patients were diagnosed with autoimmune diseases (4 with complete IPAF,and 7 with incomplete IPAF) . According to Cox regression analysis,completely meet the criteria of IPAF was related to the relapse of disease.
There exist relation between IPAF and autoimmune diseases. The patients with IPAFmay finally develop into autoimmune diseases. The IPAF classification criteria provide basic structure for this disease,but the limitation of the criteria call for revising by more clinical trials.
分析具有自身免疫特征的间质性肺炎(IPAF)的临床特征及其之间的相关性。
我们分别分析了2014年1月至2017年1月在我院收治的间质性肺疾病(ILD)患者。招募符合所有先验要求且至少具有一个领域的一个特征的患者,并分析其临床特征和自身免疫性疾病相关预后。
共招募90例患者,其中38例完全符合IPAF分类标准,52例不完全符合。平均年龄为(62.34±14.98)岁。完全IPAF患者的肺炎模式为非特异性间质性肺炎(NSIP),而不完全IPAF患者通常为寻常型间质性肺炎(UIP)。随访期间,11例患者被诊断为自身免疫性疾病(4例完全IPAF,7例不完全IPAF)。根据Cox回归分析,完全符合IPAF标准与疾病复发有关。
IPAF与自身免疫性疾病之间存在关联。IPAF患者最终可能发展为自身免疫性疾病。IPAF分类标准为此疾病提供了基本框架,但该标准的局限性需要更多临床试验进行修订。